Prime Medicine Announces First Patient Dosed In Phase 1/2 Trial Of PM577a In Wilson Disease; Receives FDA Rare Pediatric Disease Designation

뉴스 본문을 불러오고 있어요.

Prime Medicine Announces First Patient Dosed In Phase 1/2 Trial Of PM577a In Wilson Disease; Receives FDA Rare Pediatric Disease Designation | 웨이프 WAPE

Prime Medicine Announces First Patient Dosed In Phase 1/2 Trial Of PM577a In Wilson Disease; Receives FDA Rare Pediatric Disease Designation

기사 요약

관련 종목

댓글 —